Early benefit assessments Archives — Page 7 of 12 — German Market Access

G-BA decisions from 3 Aug 2023

Here are the G-BA decisions from the G-BA meeting held on 3 August 2023 on the early benefit assessments of Fintepla and

Here are the G-BA decisions from the G-BA meeting held on 20 July 2023 on the early benefit assessments of Enhertu, Imbruvica,

Here are the G-BA decisions from the G-BA meeting held on 12 May 2023 on the early benefit assessments of Tezpire, Adtralza

Here are the G-BA decisions from the G-BA meeting held on 20 April 2023 on the early benefit assessments of Ultomiris, Genvoya,

Since 2020, the G-BA can request real-world evidence data collection in Germany. However, so far this was only implemented for one product,